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Abstract
Sakacin A was purified to homogeneity through simple chromatographic pro-
cedures from cultures of Lactobacillus sakei DSMZ 6333 grown on a low-cost
medium. The highly purified protein dissipated both transmembrane potential
(DΨ) and transmembrane pH gradient (DpH) in Listeria cells in a very intense,
rapid, and energy-dependent fashion. On a slower timescale, purified sakacin A
also showed a lytic activity toward isolated cell walls of Listeria. Mass spec-
trometry was used to analyze the products of sakacin A action on cell walls,
evidencing that sakacin A acts on various types of bonds within peptoglycans.
Introduction
Consumers are demanding high-quality foods, with
minimal processing and low preservative levels (Batdorj
et al., 2007). Natural and safe substances may represent
an alternative to chemicals for inhibiting the growth of
undesirable microorganisms. Bacteriocins from lactic
acid bacteria can protect food against spoilage or pre-
vent growth of pathogenic bacteria (Cotter et al., 2005)
and are rapidly digested by humans (Deraz et al.,
2005). Class IIa bacteriocins are of the greatest interest,
because of strong antimicrobial activity against Listeria
spp.
This has stimulated investigation on rapid and
cost-effective purification protocols and on functional
characterization of these compounds. Standard purifica-
tion methods include salt precipitation, followed by gel
filtration, ion-exchange, and reverse-phase chromatogra-
phy. These methods are time-consuming and low-yielding
(Guyonnet et al., 2000) and have been improved some-
what using cation-exchange chromatography (Berjeaud &
Cenatiempo, 2004).
Sakacin A is a class IIa bacteriocin produced by
Lactobacillus sakei DSMZ 6333, able to inhibit the
growth of several lactic acid bacteria and of Listeria
monocytogenes. This bacteriocin is a small heat-stable
protein with no posttranslational modifications (Schil-
linger & Lucke, 1989). All class IIa bacteriocins have a
highly conserved N-terminal domain with the consen-
sus motif YGNGV responsible for activity against Liste-
ria (Richard et al., 2004). Upon exposure to these
bacteriocins, leakage of ions and small molecules from
sensitive cells accompanies dissipation of the proton
motive force and depletion of intracellular ATP (Drider
et al., 2006).
We report here on: (1) purification of the bacterio-
cin produced by L. sakei, cultured in a low-cost med-
ium (Trinetta et al., 2008a) of potential industrial
interest; (2) the mechanism of action of the purified
bacteriocin on Listeria cells; and (3) some mechanistic
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aspects of the lytic activity of sakacin A toward Listeria
cell walls.
Materials and methods
Bacterial strains and culture conditions
Lactobacillus sakei DSMZ 6333 (DSMZ, Braunschweig,
Germany) was cultured in an inexpensive culture medium
broth (Trinetta et al., 2008a). Listeria ivanovii ATCC
BAA-678 grown in Tryptic Soy Agar (Difco Laboratories,
Sparks, MD) for 18 h at 37 °C was used as an indicator
strain. Stocks were maintained at  20 °C in appropriate
liquid media containing 10% (w/v) glycerol and propa-
gated twice before use.
Protein purification
Sakacin A was purified from 1 L cultures of L. sakei, grown
at 30 °C for 18 h. Cells were centrifuged (10 000 g,
35 min, 4 °C). The cell-free supernatant was made 50 mM
in sodium acetate, and the pH was adjusted to 4.5 with
acetic acid/NaOH. The resulting solution was loaded onto
a SP-Sepharose fast flow cation exchange column
(4 9 11.3 cm; Whatman). Proteins were eluted stepwise
with 0.2 and 1 M NaCl, and fractions were assayed for
antimicrobial activity (Batdorj et al., 2007). The active
fraction was applied on a 10 9 250 mm reversed phase
(RP) C18 column (300 Aˆ pores, 10 lm, Labservice; Analy-
tica, Milan, Italy) run on a Waters HPLC (625 LC,
Toronto, Canada) and equilibrated with 95% (v/v) solvent
A [0.1% aqueous trifluoroacetic acid (TFA)] and 5% (v/v)
solvent B (0.1% aqueous TFA, 80% acetonitrile). Step-
wise elution by increasing acetonitrile concentration (to
30%, 50% and 80%) was carried out at a flow rate of
1.5 mL min1. The active fraction, eluted at 50% acetoni-
trile, was loaded on a Superdex Peptide column (Amer-
sham Biosciences, Milan, Italy) equilibrated in aqueous
20% (v/v) acetonitrile containing 0.01% (v/v) TFA. The
final chromatographic step was carried out on a
4.6 9 250 mm RP Symmetry C18 column (5 lm, 100 Aˆ;
Waters, Milan, Italy) equilibrated with 95% (v/v) solvent
A and 5% (v/v) solvent B. Sakacin A was eluted with a
linear gradient from 20% to 60% of solvent B for 20 min
at a flow rate of 0.8 mL min1.
SDS-PAGE and mass spectrometry
Tricine SDS-PAGE was carried out in precast 12% acryl-
amide gels (NuPage®; Invitrogen, Milan, Italy). Markers
covered the range from 3.5 to 260 kDa (Novex Sharp
Pre-Stained Standard; Invitrogen). One half of the gel was
stained with Coomassie Blue (Symply-Blue Safestain; In-
vitrogen), whereas the other half was washed with sterile
water and overlaid with soft nutrient agar medium
(10 mL) containing the indicator strain. Antimicrobial
activity was assessed after incubation at 37 °C (Yamamoto
et al., 2003).
MALDI-TOF/MS (matrix-assisted laser desorption/ioni-
sation-time of flight mass spectrometry) measurements
were carried out on a Voyager DEPRO spectrometer
(PerSeptive Biosystems, Framingham, MA) equipped with
an N2 laser (337 nm, 3 ns pulse width) operated in the
positive reflector ion mode and using delay extraction.
For assessing the purity and mass of sakacin A, the pep-
tide was co-crystallized with 2,5-dihidroxybenzoic acid
(DHB) and a-cyano-4-
hydroxycinnamic acid (CHCA), both at 10 mg mL1 in
50% acetonitrile (v/v)/0.1% (v/v) TFA. External mass cal-
ibration was performed with low-mass peptide standards
(PerSeptive Biosystems).
For the characterization of products of cell wall break-
down, postsource decay (PSD) fragment ion spectra were
obtained after isolation of the appropriate precursor using
timed ion selection. Fragment ions were refocused onto
the final detector by stepping the voltage applied to the
reflector and individual segments combined using PERSEP-
TIVE BIOSYSTEMS software (De Simone et al., 2009). CHCA
was used in this study according to Boneca et al., 2000.
The sample (1 lL, in water) was loaded on the target,
dried, and re-dissolved in CHCA (1 lL, 10 mg mL1 in
0.1% TFA in 50% aqueous acetonitrile). For each sample,
200 laser pulses were accumulated.
Determination of protein concentration and
bacteriocin activity (AU mL1)
Concentration of purified sakacin A was calculated
by assuming e280 = 14 105 (mol
1 cm1; http://web.expasy.
org/protparam/; Kelly et al., 2005). The bacteriocin titer was
determined by a serial dilution assay, activity being defined
as the reciprocal of the last serial dilution that exhibited a
clear zone of inhibition and being expressed as activity units
(AU; De Kwaadsteniet et al., 2005).
Measurement of transmembrane potential
(DΨ)
Changes in the cell transmembrane electrical potential
were measured by quenching of the potential-sensitive
fluorescent probe 3, 3-dipropylthiadicarbocyanine iodide
(diSC3; Molecular Probes Inc., Eugene, OR; Deraz et al.,
2005). Cells were suspended in 50 mM potassium-
HEPES, pH 7, containing 0.2% glucose (final OD600 nm =
0.4), to give glucose-energized cells. The probe (5 lM)
and nigericin (1.5 lM) were mixed with the glucose-
ª 2012 Federation of European Microbiological Societies FEMS Microbiol Lett && (2012) 1–7
Published by Blackwell Publishing Ltd. All rights reserved
2 V. Trinetta et al.
energized cell suspension, and sakacin A (80 AU mL1)
or valinomycin (1.5 lM) was added as appropriate. Fluo-
rescence was measured at 30 °C in a spectrofluorometer
(Model LS 50; PerkinElmer, Milan, Italy), with excitation
at 643 nm and emission at 666 nm (Suzuki et al., 2005).
Measurement of transmembrane pH (DpH)
Changes in the transmembrane pH gradient were mea-
sured with the pH-sensitive fluorescent probe 5 (and 6)
carboxyfluorescein diacetate succinimidyl ester (cFDASE;
Molecular Probes Inc.; McAuliffe et al., 1998). The cells
were concentrated threefold in 1.5 mL of 50 mM potas-
sium-HEPES buffer, pH 8, and then incubated at 30 °C
for 10 min with the probe (1 lM). Nonconjugated probe
was eliminated by incubating the cells with 10 mM lac-
tose at 30 °C for 30 min. The cells were washed twice,
suspended in 50 mM potassium phosphate buffer at pH
7 and placed on ice until used. The intracellular pH was
determined by diluting the lactose-loaded cells to a con-
centration of 107 CFU mL1 in a 3-mL glass cuvette. Flu-
orescence was measured as reported earlier.
Preparation of cell walls and cell wall
breakdown measurements
Bacterial cell walls were isolated according to Simelyte et al.
(2000). Harvested Listeria cells (107 CFU mL1) were heat-
treated at 80 °C for 30 min to inactivate autolytic enzymes,
collected by centrifugation at 17 000 g for 10 min, and sus-
pended in 3 mL of 10 mM phosphate buffer (pH 7). The
suspension was disrupted with a MSK Cell Homogenizer
(Braun Biotech, Goettingen, Germany) using glass beads
(five 1-min cycles). A pellet collected by centrifugation at
20 000 g for 10 min at 4 °C was suspended as above and
treated for 1 h at 37 °C with DNase (25 lL, 5 U lL1)
and RNase A (25 lL, 100 mg mL1) and 1 h at 37 °C with
trypsin (250 lg mL1). All hydrolytic enzymes were from
Sigma-Aldrich (Milan, Italy). Following ultracentrifugation
(100 000 g, 60 min, 4 °C; Beckman L7-65 Instruments,
Gagny, France), the pellet was suspended in 3 mL of phos-
phate buffer and sonicated for 10 min in an ice bath. Resid-
ual cell wall-associated proteins were removed by papain
treatment (3 lL, 50 mg mL1 solution; Sigma-Aldrich) for
1 h at 37 °C, followed by ultracentrifugation.
For the cell wall breakdown assay, the pellet from
ultracentrifugation was suspended in 6 mL of 10 mM
phosphate (pH 7) and divided into four aliquots that
were treated with vancomycin (100 lg mL1), lysozyme
(100 lg mL1), sakacin A (80 AU mL1, 100 lg mL1),
or left untreated. The absorbance at 600 nm was mea-
sured after incubation at 30 °C (30 min and 24 h). Sam-
ples were frozen, lyophilized, and used as such for
subsequent MS analysis of released products. In a separate
set of experiments, aliquots of the same cell wall prepara-
tions were treated overnight (16 h) at 30 °C with increas-
ing amounts of sakacin A (from 0 to 300 lg, equivalent
to 0–240 AU) and analyzed by MS.
Statistical analysis
All experiments were performed in triplicate. Statistical
analysis was carried out using a Tukey’s multiple
comparison test (Minitab 15v, State College, PA) and dif-
ferences considered significant at P < 0.05.
Results
Purification and characterization of sakacin A
Sakacin A was purified through a sequence of chromato-
graphic steps from L. sakei cultures propagated in an
inexpensive broth (Trinetta et al., 2008a). Sakacin A was
eluted at c. 0.45 M NaCl from a cation exchanger at pH
4.5, confirming its cationic character and was further
purified through RP and gel-permeation HPLC. A final
RP-HPLC step eliminated a minor contaminant (Sup-
porting Information, Fig. S1) and gave 1.7 mg of purified
sakacin A L1 of the original culture (Table S1).
The highly purified material showed a single band in
SDS-PAGE, with a molecular mass of c. 4000 Da
(Fig. 1a). The band retained antimicrobial activity against
L. ivanovii (Fig. 1b), highlighting a peculiar resistance of
the protein to denaturation as suggested also by activity
(a)
(b)
Fig. 1. Tricine-SDS-PAGE profiles of purified sakacin A and detection
of antimicrobial activity on the gel. (a) Comassie Blue stained gel, the
left lane represents the protein molecular mass marker and the other
lane the purified sakacin A; (b) gel overlaid with Listeria ivanovii to
determine the antimicrobial activity of the purified bacteriocin.
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retention at the high acetonitrile concentrations used in
RP-HPLC.
Purity and identity of the isolated material and corre-
spondence to a published sequence (Holck et al., 1992)
were established by MALDI-TOF MS (Figure S2). The
observed molecular mass (4302.36 Da) agrees with the
sequence-calculated monoisotopic (4302.89 Da) and aver-
age isotopic (4306.89 Da) values.
Effect of sakacin A on Listeria cells: rapid
dissipation of DΨ and DpH
The effects of sakacin A on the individual components of
the proton motive force (PMF) (namely, DΨ and DpH)
on Listeria cells were studied. In all the experiments
described later, highly purified sakacin A was used at a
concentration close to the MIC determined in previous
studies (Trinetta et al., 2008b).
The potential-sensitive fluorescent cyanine dye diSC3
(5) was used for assessing the sakacin A-induced dissipa-
tion of DΨ. By adding glucose to Listeria cells, a nega-
tive-inside DΨ was generated, resulting in the quenching
of the probe fluorescence as a consequence of probe accu-
mulation within the cells. As shown in Fig. 2, Listeria
cells were able to maintain DΨ in the presence of nigeri-
cin (arrow 4) that dissipates transmembrane DpH.
When sakacin A was added to glucose-energized and
nigericin-treated cells, the fluorescence of the probe
increased, as a result of its release from the cell interior
(arrow 5). This indicates a depolarization of the cytoplas-
mic membrane consequent to the addition of sakacin A.
Figure 4 also makes it evident that the decrease in fluo-
rescence induced by the addition of glucose has an ampli-
tude very similar to the fluorescence increase ensuring
from the addition of sakacin A. The ionophore valinomy-
cin was used at the end of these experiments (arrow 6) to
completely dissipate DΨ (McAuliffe et al., 1998).
The pH-sensitive fluorescent probe cFDASE was used to
assess the transmembrane DpH in Listeria cells. As also
shown in Fig. 2, the fluorescence of the probe rapidly
increased upon addition of lactose to cells (arrow 1), conse-
quent to increased internal pH. When sakacin A was added
(arrow 2), a rapid decrease in the signal was observed. No
further signal increase was observed when nigericin was
added (arrow 3), indicating that sakacin A completely dis-
sipated the transmembrane DpH of Listeria cells.
Effects on the cell walls
The effects of sakacin A on isolated cell walls were stud-
ied by measuring the time course of turbidity decrease in
cell wall suspensions at sakacin A concentration close to
the MIC. As shown in Table 1, turbidity decreased by
c. 20% within 30 min of sakacin A addition. After 24 h,
the sample treated with sakacin A gave a turbidity
decrease (38–40%) not significantly different (P > 0.05)
from that obtained with lysozyme.
Isolated Listeria cell walls were exposed to various anti-
microbials, and the solubilized material was analyzed by
Fig. 2. Effect of sakacin A on the DΨ and DpH in Listeria cells as
monitored through fluorescent probes. Top, DΨ. Arrows indicate the
additions of the following: 1, diSC3(5) probe; 2, Listeria cells; 3,
10 mM glucose; 4, 1 mM nigericin; 5, 80 AU mL1 sakacin A; 6,
valinomycin. Bottom, DpH. The following additions to suspensions of
Listeria cells containing the cFDASE probe are indicated by arrows: 1,
lactose 10 mM; 2, 80 AU mL1 sakacin A; 3, 1 mM nigericin. In both
experiments, fluorescence was monitored at an excitation wavelength
of 643 nm and an emission wavelength of 666 nm.
Table 1. Optical density at 600 nm of Listeria cell wall isolates
treated with lysozyme and sakacin A
Time (hours) Control Lysozyme Sakacin A
0 0.527 ± 0.02a 0.540 ± 0.04a 0.534 ± 0.04a
0.5 0.501 ± 0.06a 0.499 ± 0.05a 0.436 ± 0.01b
24 0.509 ± 0.02a 0.335 ± 0.03b 0.330 ± 0.02b
Values are presented as means ± SD. In the same row, numbers with
the same superscript are not significantly different (P > 0.05).
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MALDI-TOF MS. The differences in the MS spectra in
Fig. 3 indicate that individual antimicrobials had specific
mechanisms of action and suggest that Listeria cell walls
were broken down by sakacin A into fragments in the
1000–2500 Da range.
In separate set of experiments, isolated Listeria cell walls
were treated for 24 h at 30 °C with increasing amounts of
sakacin A, and the released fragments (Fig. 4) were
sequenced by MS/MS. No fragments were released in the
absence of sakacin A or with sakacin A concentrations
Fig. 3. MALDI-TOF profile of the water-soluble fraction from isolated cell walls incubated for 24 h at 30 °C in the presence of equivalent
concentrations (0.1 mg mL1) of the given antimicrobials. (a) control samples, where vancomycin was present; (b) cell wall isolates incubated
with sakacin A; (c) cell wall isolates incubated with lysozyme.
Fig. 4. MALDI-TOF profile of the water-soluble fraction from isolated cell walls incubated for 16 h at 30 °C with high concentrations of sakacin
A (0.3 mg mL1).
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lower than 0.1 mg mL1. As summarized in Table 2,
products containing fragments from both the polysaccha-
ride and the peptide components of the peptoglycan were
evident at sakacin A concentrations of 0.1 mg mL1, and
further breakdown products originating by former
‘primary cuts’ were evident only at higher sakacin A con-
centrations (Fig. 4).
PSD analysis of the fragments revealed the partial struc-
tures reported in Table 2. From the sequences of these
products, sakacin A also seems to elicit proteolytic activity,
with a preference for the bond formed by the N-acetyl
muramic acid (NAM)-linked L-alanine residue nearest to
the polysaccharide chain in the peptoglycan. Thus, the spe-
cific action of sakacin A on Listeria cell walls resulted in
breakdown of the peptoglycan component in a fashion
similar to lysozyme, but with a different specificity.
Discussion
The purification of sakacin A produced by L. sakei DSMZ
6333 from bacteria cultured in a low-cost media formula-
tion, based on industrial ingredients and/or residuals from
agro-food production (Trinetta et al., 2008a), through
the procedure reported here, compares favorably with
protocols using higher-cost media and resulting in lower
purification yields. The availability of significant amounts
of purified sakacin A made it possible to investigate its
mode of action.
We confirmed sakacin A as a membrane-active bacte-
riocin that kills Listeria cells by making their membranes
permeable (Kaiser & Montville, 1996; Ennahar et al.,
1998). The cytoplasmic membrane seems the primary
target of sakacin A, whose action is enhanced when cells
are energized, possibly because transmembrane gradients
favor the bacteriocin interaction with the membrane.
The sakacin A action is straightforward and intense:
both DΨ and DpH are completely dissipated in seconds,
resulting in leakage of cellular material (McAuliffe et al.,
1998).
One suggested mechanism of action for class IIa bacte-
riocins is the ‘barrel-stave model’ that implies an electro-
static binding step mediated by a membrane-bound
receptor followed by a step involving hydrophobic interac-
tion of an amphiphilic bacteriocin domain with the lipid
acyl chains and in pore formation (Ennahar et al., 1998;
Drider et al., 2006). However, other hypothetical mecha-
nisms of action for class II bacteriocins imply a direct effect
on cell walls (Kabuki et al., 1997; Nielsen et al., 2003).
Our observations, obtained with a highly purified bacte-
riocin preparation, support that cell walls are a target for
sakacin A. A similar mode of action was shown by enteroly-
sin A on Listeria innocua cell walls, where the activity was
muralytic (Nielsen et al., 2003). Enterococcus mundtii ST15
produced a bacteriocin active against Gram-positive and
Gram-negative bacteria that displays a lytic action toward
growing cells of Lactobacillus casei (De Kwaadsteniet et al.,
2005). El Ghachi et al. (2006) investigated the lytic action
of colicin M on Escherichia coli cell walls by HPLC and
MALDI-TOF MS analysis, similar to our study.
The data presented here confirm a slow hydrolytic
action of sakacin A toward Listeria cell walls and suggest
that sakacin A can break specific peptide bonds in the
peptoglycan structure. This ‘proteolytic’ activity accompa-
nies the capability of sakacin A to hydrolyze the b-1,4
glycosidic bond in NAM-NAG units and complements
the effects on membrane structure discussed earlier, thus
contributing to the efficacy (and selectivity) of this anti-
microbial molecule.
In conclusion, purified sakacin A shows a dual mecha-
nism of action: (1) it acts rapidly by changing the electrical
charge distribution across the membrane and consequently
dissipating the PMF; and (2) it slowly breaks down cell
walls of sensitive bacteria, acting on both the polysaccha-
ride and peptide components of the cell wall peptoglycan.
This second activity might be useful to decrease the num-
ber of bacteria that compete for limiting nutrients in the
same environment (Nielsen et al., 2003).
The strong anti-Listeria activity of sakacin A, the high
bacteriocin titer obtained at the end of the purification,
and the application of a low-cost media formulation pave
the use of this bacteriocin as an antimicrobial agent in food
systems to prevent the growth of spoilage and pathogen
bacteria and improve quality, safety, and food shelf life.
Table 2. Mass and structural data for products of cell wall hydrolysis
by different amounts of sakacin A. Treatment of cell wall suspensions
was performed overnight (c. 18 h) at 30 °C. Amino acids in the
sequences are given as single letter symbols. Other abbreviations are
as follows: DPM, diaminopimelic acid; NAG, N-acetyl glucosamine.




A added to cell
walls, mg
0.1 0.2 0.3
2392 2392 2392 NAG-NAM-(A)-NAG-NAM-A-E-DPM-A-A-DPM-
E-A-NAM-NAG









ª 2012 Federation of European Microbiological Societies FEMS Microbiol Lett && (2012) 1–7
Published by Blackwell Publishing Ltd. All rights reserved
6 V. Trinetta et al.
References
Batdorj B, Trinetta V, Prevost H, Dousset X, Haertle T &
Chobert JM (2007) Isolation, taxonomic identification and
hydrogen peroxide production by Lactobacillus delbrueckii
subsp. Lactis T31, isolated from Mongolian yoghurt:
inhibition activity on food-borne pathogens. J Appl
Microbiol 103: 584–593.
Berjeaud JM & Cenatiempo Y (2004) Purification of
antilisterial bacteriocins. Methods Mol Biol 268: 225–233.
Boneca IG, Huang Z-H, Gage DA & Tomaszi A (2000)
Characterization of Staphylococcus aureus cell wall glycan
strands, evidence for a new b-N-acetyglucosaminidase
activity. J Biol Chem 275: 9910–9918.
Cotter PD, Hill C & Ross RP (2005) Bacteriocins: developing
innate immunity for food. Nat Rev Microbiol 3: 777–788.
De Kwaadsteniet M, Todorov SD, Knoetze H & Dicks LMT
(2005) Characterization of a 3944 Da bacteriocin, produced
by Enterococcus mundtii ST15, with activity against Gram-
positive and Gram-negative bacteria. Int J Food Microbiol
105: 433–444.
De Simone C, Picariello G, Mamone G, Stiuso P, Dicitore A,
Vanacore D, Chianese L, Addeo F & Ferranti P (2008)
Characterisation and cytomodulatory properties of peptides
from Mozzarella di Bufala Compana cheese whey. J Pept Sci
15: 251–258.
Deraz SF, Nordberg KE, Hedstro¨ma M, Andersson MM &
Mattiasson B (2005) Purification and characterisation of
acidocin D20079, a bacteriocin produced by Lactobacillus
acidophilus DSM 20079. J Biotechnol 117: 343–354.
Drider D, Fimland G, Hechard Y, McMullen LM & Prevost H
(2006) The continuing story of class IIa bacteriocin.
Microbiol Mol Biol Rev 70: 564–582.
El Ghachi M, Bouhss A, Barreteau H, Touze T, Auger G,
Blanot D & Mengin-Lecreulx D (2006) Colicin M exerts its
bacteriolytic effect via enzymatic degradation of
undecaprenyl phosphate-linked peptoglycan precursors.
J Biol Chem 281: 22761–22772.
Ennahar S, Assobhei O & Hasselmann C (1998) Inhibition of
Listeria monocytogenes in a smear-surface soft cheese by
Lactobacillus plantarum WHE 92, a pediocin AcH producer.
J Food Prot, 61: 186–191.
Guyonnet D, Fremaux C, Cenatiempo Y & Berjeaud JM
(2000) Method for rapid purification of class IIa
bacteriocins and comparison of their activities. Appl Environ
Microbiol 66: 1744–1748.
Holck A, Axelsson L, Birkeland SE, Aukrust T & Blom H
(1992) Purification and amino acid sequence of sakacin A, a
bacteriocin from Lactobacillus sakei Lb706. J Gen Microbiol
138: 2715–2720.
Kabuki T, Saito T, Kawai Y, Uemura J & Itoh T (1997)
Production, purification and characterization of reutericin 6,
a bacteriocin with lytic activity produced by Lactobacillus
reuteri LA6. Int J Food Microbiol 34: 145–156.
Kaiser AL & Montville TJ (1996) Purification of the
bacteriocin Bavaricin MN and characterization of its mode
of action against Listeria monocytogenes Scott A cells and
lipid vesicles. Appl Environ Microbiol 62: 4529–4535.
Kelly SM, Jess TJ & Price C (2005) How to study proteins by
circular dichroism. Biochim Biophys Acta 1751: 119–139.
McAuliffe O, Ryan MP, Ross PR, Hill C, Breeuwer P & Abee
T (1998) Lactacin 3147, a broad-spectrum bacteriocin which
selectively dissipates the membrane potential. Appl Environ
Microbiol 64: 439–445.
Nielsen T, Nes IF & Holo H (2003) Enterolysin A, a cell wall-
degrading bacteriocin from Enterococcus faecalis LMG 2333.
Appl Environ Microbiol 69: 2975–2984.
Richard C, Drider D, Elmorjani K, Marion D & Prevost H
(2004) Heterologous expression and purification of active
divercin V41, a class IIa bacteriocin encoded by a synthetic
gene in Escherichia coli. J Bacteriol 186: 4276–4284.
Schillinger U & Lucke FK (1989) Antibacterial activity of
Lactobacillus sake isolated from meat. Appl Environ Microbiol
55: 1901–1906.
Simelyte E, Rimpila M, Lehtonen L, Zhang X & Toivanen P
(2000) Bacterial cell wall-induced arthritis: chemical
composition and tissuedistribution of four Lactobacillus
strains. Infect Immun 68: 3535–3540.
Suzuki M, Yamamoto T, Kawai Y, Inoue N & Yamazaki K
(2005) Mode of action of piscicocin CS526 produced by
Carnobacterium piscicola CS526. J Appl Microbiol 98:
1146–1151.
Trinetta V, Rollini M & Manzoni M (2008a) Development of
a low cost culture medium for sakacin A production by
L. sakei. Process Biochem 43: 1275–1280.
Trinetta V, Rollini M, Limbo S & Manzoni M (2008b)
Influence of temperature and sakacin A concentration on
survival of Listeria innocua cultures. Ann Microb 58:
633–639.
Yamamoto Y, Togawa Y, Shimosaka M & Okazaki M (2003)
Purification and characterization of a novel bacteriocin
produced by Enterococcus faecalis strain RJ-11. Appl Environ
Microbiol 69: 5746–5753.
Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Fig. S1. Elution profile of sakacin A from a (RP) C18 col-
umn, with a linear gradient from 20 to 60% acetonitrile
in water containing 0.1% TFA (dotted lines).
Fig. S2. MALDI-TOF mass spectrometric analysis of saka-
cin A.
Table S1. Purification of sakacin A.
Please note: Wiley-Blackwell is not responsible for the
content or functionality of any supporting materials sup-
plied by the authors. Any queries (other than missing
material) should be directed to the corresponding author
for the article.
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